Brandon Couillard
Stock Analyst at Wells Fargo
(4.70)
# 157
Out of 5,139 analysts
174
Total ratings
67.96%
Success rate
19.13%
Average return
Main Sectors:
Stocks Rated by Brandon Couillard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Equal-Weight | $385 → $415 | $387.37 | +7.13% | 7 | Dec 15, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Overweight | $635 → $675 | $618.72 | +9.10% | 8 | Dec 15, 2025 | |
| RVTY Revvity | Maintains: Equal-Weight | $102 → $107 | $112.50 | -4.89% | 3 | Dec 15, 2025 | |
| RGEN Repligen | Maintains: Overweight | $175 → $190 | $162.02 | +17.27% | 3 | Dec 15, 2025 | |
| MTD Mettler-Toledo International | Maintains: Equal-Weight | $1,400 → $1,450 | $1,460.63 | -0.73% | 7 | Dec 15, 2025 | |
| MLAB Mesa Laboratories | Maintains: Equal-Weight | $75 → $83 | $88.69 | -6.42% | 4 | Dec 15, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Overweight | $4 → $4.5 | $3.92 | +14.80% | 2 | Dec 15, 2025 | |
| DHR Danaher | Maintains: Equal-Weight | $230 → $240 | $235.99 | +1.70% | 5 | Dec 15, 2025 | |
| BRKR Bruker | Maintains: Overweight | $48 → $55 | $48.39 | +13.66% | 7 | Dec 15, 2025 | |
| NTRA Natera | Maintains: Equal-Weight | $190 → $205 | $231.25 | -11.35% | 3 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $93 → $120 | $112.14 | +7.01% | 2 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $155 | $108.08 | +43.41% | 6 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $18 | $20.01 | -10.04% | 4 | Dec 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $110 | $88.73 | +23.97% | 1 | Dec 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $150 → $175 | $139.64 | +25.32% | 25 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $90 → $105 | $102.43 | +2.51% | 19 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $70 | $68.67 | +1.94% | 2 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $6.5 | $5.92 | +9.80% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $313.53 | +8.44% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $265 → $340 | $323.10 | +5.23% | 13 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $19 → $16 | $12.16 | +31.58% | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $260 | $171.49 | +51.61% | 11 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $77 → $80 | $79.98 | +0.03% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $30 → $23 | $25.24 | -8.87% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $2.00 | +550.00% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.69 | - | 11 | Nov 2, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.67 | +558.68% | 2 | Oct 13, 2017 |
Waters
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $385 → $415
Current: $387.37
Upside: +7.13%
Thermo Fisher Scientific
Dec 15, 2025
Maintains: Overweight
Price Target: $635 → $675
Current: $618.72
Upside: +9.10%
Revvity
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $102 → $107
Current: $112.50
Upside: -4.89%
Repligen
Dec 15, 2025
Maintains: Overweight
Price Target: $175 → $190
Current: $162.02
Upside: +17.27%
Mettler-Toledo International
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $1,400 → $1,450
Current: $1,460.63
Upside: -0.73%
Mesa Laboratories
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $83
Current: $88.69
Upside: -6.42%
Maravai LifeSciences Holdings
Dec 15, 2025
Maintains: Overweight
Price Target: $4 → $4.5
Current: $3.92
Upside: +14.80%
Danaher
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $230 → $240
Current: $235.99
Upside: +1.70%
Bruker
Dec 15, 2025
Maintains: Overweight
Price Target: $48 → $55
Current: $48.39
Upside: +13.66%
Natera
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $190 → $205
Current: $231.25
Upside: -11.35%
Dec 15, 2025
Maintains: Overweight
Price Target: $93 → $120
Current: $112.14
Upside: +7.01%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $140 → $155
Current: $108.08
Upside: +43.41%
Dec 15, 2025
Maintains: Equal-Weight
Price Target: $14 → $18
Current: $20.01
Upside: -10.04%
Dec 1, 2025
Initiates: Equal-Weight
Price Target: $110
Current: $88.73
Upside: +23.97%
Nov 25, 2025
Maintains: Overweight
Price Target: $150 → $175
Current: $139.64
Upside: +25.32%
Nov 24, 2025
Downgrades: Hold
Price Target: $90 → $105
Current: $102.43
Upside: +2.51%
Nov 6, 2025
Maintains: Overweight
Price Target: $59 → $70
Current: $68.67
Upside: +1.94%
Nov 5, 2025
Maintains: Equal-Weight
Price Target: $6 → $6.5
Current: $5.92
Upside: +9.80%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $313.53
Upside: +8.44%
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $265 → $340
Current: $323.10
Upside: +5.23%
Aug 4, 2025
Maintains: Overweight
Price Target: $19 → $16
Current: $12.16
Upside: +31.58%
Jan 23, 2025
Maintains: Buy
Price Target: $285 → $260
Current: $171.49
Upside: +51.61%
Jan 23, 2025
Maintains: Hold
Price Target: $77 → $80
Current: $79.98
Upside: +0.03%
Feb 9, 2024
Downgrades: Hold
Price Target: $30 → $23
Current: $25.24
Upside: -8.87%
Jul 13, 2021
Initiates: Buy
Price Target: $13
Current: $2.00
Upside: +550.00%
Nov 2, 2017
Downgrades: Hold
Price Target: n/a
Current: $2.69
Upside: -
Oct 13, 2017
Maintains: Buy
Price Target: $9 → $11
Current: $1.67
Upside: +558.68%